BECKMAN COULTER IRISpec CA/CB/CC control, REF 900-7211, For in vitro diagnostic use only.
FDA Recall Z-0777-2023 · Posted 2023-01-03
Advertisement
Recalling FirmBeckman Coulter, Inc.
Recall StatusOpen, Classified
Product CodeJJW
Date Initiated2022-11-18
Product Quantity3657 units
Reason for Recall
Beckman Coulter has become aware of an increase in customer complaints generated for intermittent IRISpec CB glucose control false positive results when used in conjunction with iChemVelocity Urine Chemistry Strips PN 800-7212
Firm Action
The firm issued a MEDICAL DEVICE RECALL notice to its consignees on 11/18/2022 by mail and email. The notice explained the problem and requested the following actions be taken:
"If IRISpec CB controls pass (QC results are within QC acceptance
criteria):
Continue to process patient samples per IFU (P/N 301-7146BE)
If IRISpec CB controls fail (QC results are outside QC acceptance
criteria):
Refer to Addendum A below for troubleshooting
No retrospective review of QC or patient sample results is necessary."
"Please share this information with your laboratory staff and retain this notification as part of your laboratory Quality System documentation. If you have forwarded any of the affected product listed above to another laboratory, please provide them a copy of this letter."
Root Cause
Under Investigation by firm
Distribution Pattern
US and Canada, Brazil, Korea, Mexico, Puerto Rico, Taiwan
Related FDA 510(k) Records
Devices referenced by this recall via K-numbers.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement